Disnea y bloqueo de rama derecha en un adulto joven / No disponible

No disponible

Plasma status of retinol, alpha- and gamma-tocopherols, and main carotenoids to first myocardial infarction: case control and follow-up study.

OBJECTIVE: Epidemiologic studies have suggested that dietary intake and plasma concentrations of antioxidants have an inverse relation with coronary heart disease. To test whether fat-soluble antioxidants can play a role against the occurrence of myocardial infarction (MI), we measured plasma levels of retinol, tocopherols, and individual carotenoids in MI patients. METHODS: A case-control and follow-up study of patients in the Móstoles area (Madrid, Spain). One hundred six patients (62 after 1 y) and 104 control subjects participated in the study. Blood samples were collected after overnight fast or during the first 24 h of MI onset for biochemical profiles of retinol, alpha- and gamma-tocopherols, and carotenoid by means of a quality-controlled high-performance liquid chromatography. RESULTS: During the acute phase after MI onset, plasma levels of retinol, gamma-tocopherol, and xanthophylls (lutein/zeaxanthin and beta-cryptoxanthin) decreased, whereas alpha-tocopherol, alpha-carotene, beta-carotene, and lycopene showed levels similar to those of control subjects. Logistic regression analysis showed low concentrations of gamma-tocopherol (and retinol) in plasma as the only statistically significant factor associated with MI, after adjusting for traditional risk factors. However, 1 y later, the MI patients showed a general improvement in plasma lipids and fat-soluble antioxidant status, and none of the analytes was associated with MI. CONCLUSIONS: The decreased plasma status of retinol, gamma-tocopherol, and xanthophylls during the acute phase of MI normalized the year after the MI event, suggesting that most subjects had followed an overall healthier lifestyle and dietary pattern. The results also raise concerns on the usefulness of these plasma compounds as specific, relevant, and predictive markers in relation to coronary heart disease.

[Plasma levels of vitamins A and E and the risk of acute myocardial infarct]. / Niveles plasmáticos de vitaminas A y E y riesgo de infarto agudo de miocardio.

INTRODUCTION AND OBJECTIVE: The incidence of myocardial infarction in Spain is low in spite of the high prevalence of smoking and hypertension. Natural antioxidants as vitamin E from a diet rich in fruit, oils and vegetables may protect against the development of this disease. In this study we have examine plasma levels of vitamin A and E as risk factors in the development of myocardial infarction. STUDY DESIGN: 62 cases were selected among patients 30-70 years old admitted to the hospital with a first episode of myocardial infarction, or diagnosed by arteriography of coronary heart disease. 62 controls were selected among patients with minor surgical conditions, and free of coronary heart disease according to the Rose questionnaire and ECG. LABORATORY ANALYSIS: Plasma samples for vitamin assays were taken in the first 24 hours after admission (62 cases) Plasma was separated by centrifugation and stored at -80 degrees C until plasma vitamins were determined by HPLC. RESULTS: Lipid adjusted blood levels of vitamin E were lower in cases, mean: 1092.0 +/- standard deviation 165.8 micrograms/dl (mean +/- SD) than in controls (1220.1 +/- 274.8 micrograms/dl p = 0.002). The multivariate adjusted odds ratio between extreme quintiles of blood vitamin E were 0.06 (95% confidence intervals (CI): 0.01-0.5; p for trend 0.0027. Adjusted blood levels of vitamins A were also lower in cases 44.0 +/- 15.1 micrograms/dl than in controls: (57.5 +/- 15.2 micrograms/dl; p < 0.001). Adjusted odds ratio between extreme quintiles of blood vitamin A adjusted for confounding factors were 0.06 (95% CI: 0.01-0.36; p for trend < 0.00001). CONCLUSIONS: There is an association between acute of myocardial infarction and reduce blood levels of vitamin A and E, that is not explained by the decrement in blood lipids levels. Therefore low blood levels of fat soluble vitamins may be a risk factor for the development of this disease.